Trials / Completed
CompletedNCT02469922
Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer
Prospective Study Assessing Predictive Value of 18 F-2-fluoro-2-deoxy-D-glucose Fluorodeoxyglucose (FDG) Positron Emission Tomography During Radio-chemotherapy for Locally Advanced Epidermoid Carcinoma of Head and Neck
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- Center Eugene Marquis · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Open multicentric study assessing predictive value of 18-FDG PET (SUV max) at 20 Gy during radio-chemotherapy, on the loco-regional control after 2 years
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Positron emission tomography | |
| RADIATION | radiochemotherapy | Every patients will be treated with radiochemotherapy as a standard of care |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2021-01-29
- Completion
- 2021-01-29
- First posted
- 2015-06-12
- Last updated
- 2021-07-27
Locations
5 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02469922. Inclusion in this directory is not an endorsement.